-
Je něco špatně v tomto záznamu ?
Universality of Oxime K203 for Reactivation of Nerve Agent-Inhibited AChE
K. Kuca, M. Hrabinova, D. Jun, K. Musilek, M. Penhaker, O. Krejcar, O. Soukup,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- acetylcholinesterasa metabolismus MeSH
- cholinesterasové inhibitory farmakologie MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- nervová bojová látka farmakologie MeSH
- oximy farmakologie MeSH
- pyridinové sloučeniny farmakologie MeSH
- reaktivátory cholinesterasy farmakologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Oxime K203 seems to be the most promising oxime in case of reactivation of tabun-inhibited acetylcholinesterase (AChE). Although it was originally developed for treatment of tabun intoxications, it is able to reactivate cholinesterases inhibited by other nerve agents. This study is aimed at the evaluation of its potency in vitro against other nerve agents. For this purpose, sarin, tabun, cyclosarin, soman, VX, Russian VX and DFP were selected as members of the nerve agent family to check its universality. At high concentrations (10(-3) M), oxime K203 reached promising reactivation activity. At low concentrations, relevant for human use (10(-5) M), promising reactivation potency was obtained only with tabun. In conclusion, oxime K203 reactivates other nerve agents-inhibited cholinesterases, however its broad-spectrum reactivation is limited at high, for human not attainable, concentrations only.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16028463
- 003
- CZ-PrNML
- 005
- 20161025121527.0
- 007
- ta
- 008
- 161005s2015 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/1573406411666150407154204 $2 doi
- 035 __
- $a (PubMed)25845909
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kuca, Kamil
- 245 10
- $a Universality of Oxime K203 for Reactivation of Nerve Agent-Inhibited AChE / $c K. Kuca, M. Hrabinova, D. Jun, K. Musilek, M. Penhaker, O. Krejcar, O. Soukup,
- 520 9_
- $a Oxime K203 seems to be the most promising oxime in case of reactivation of tabun-inhibited acetylcholinesterase (AChE). Although it was originally developed for treatment of tabun intoxications, it is able to reactivate cholinesterases inhibited by other nerve agents. This study is aimed at the evaluation of its potency in vitro against other nerve agents. For this purpose, sarin, tabun, cyclosarin, soman, VX, Russian VX and DFP were selected as members of the nerve agent family to check its universality. At high concentrations (10(-3) M), oxime K203 reached promising reactivation activity. At low concentrations, relevant for human use (10(-5) M), promising reactivation potency was obtained only with tabun. In conclusion, oxime K203 reactivates other nerve agents-inhibited cholinesterases, however its broad-spectrum reactivation is limited at high, for human not attainable, concentrations only.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cholinesterasové inhibitory $x farmakologie $7 D002800
- 650 _2
- $a reaktivátory cholinesterasy $x farmakologie $7 D002801
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nervová bojová látka $x farmakologie $7 D000067397
- 650 _2
- $a oximy $x farmakologie $7 D010091
- 650 _2
- $a pyridinové sloučeniny $x farmakologie $7 D011726
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hrabinova, Martina
- 700 1_
- $a Jun, Daniel
- 700 1_
- $a Musilek, Kamil
- 700 1_
- $a Penhaker, Marek
- 700 1_
- $a Krejcar, Ondrej
- 700 1_
- $a Soukup, Ondrej $u Biomedical Research Center, Uiversity Hospital Hradec Kralove, Hradec Kralove, Czech republic. kamil.kuca@fnhk.cz.
- 773 0_
- $w MED00180387 $t Medicinal chemistry (Shāriqah (United Arab Emirates)) $x 1875-6638 $g Roč. 11, č. 7 (2015), s. 683-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25845909 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20161005 $b ABA008
- 991 __
- $a 20161025121941 $b ABA008
- 999 __
- $a ok $b bmc $g 1166777 $s 953093
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 11 $c 7 $d 683-6 $i 1875-6638 $m Medicinal chemistry $n Med Chem $x MED00180387
- LZP __
- $a Pubmed-20161005
